Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy

OBJECTIVE: A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in primary HIV-1 infection (PHI) maintain viral suppression on stopping. Whether this is related to ART duration has not been explored. DESIGN: And Methods: Using SPARTAC trial data from individuals recruit...

Detaylı Bibliyografya
Asıl Yazarlar:	Stöhr, W, Fidler, S, McClure, M, Weber, J, Cooper, D, Ramjee, G, Kaleebu, P, Tambussi, G, Schechter, M, Babiker, A, Phillips, R, Porter, K, Frater, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science 2013

Benzer Materyaller

Short-course antiretroviral therapy in primary HIV infection.
Yazar:: Fidler, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection
Yazar:: Hamlyn, E, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Yazar:: Gossez, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy.
Yazar:: Frater, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients.
Yazar:: Frater, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Delivery of community-based antiretroviral therapy to maintain viral suppression and retention in care in South Africa
Yazar:: Wang, M, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
Yazar:: Fidler, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
Yazar:: Fidler, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Extended-duration transdermal nicotine therapy was more effective than standard-duration therapy for smoking cessation.
Yazar:: Lancaster, T, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
Yazar:: Foster, C, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
Yazar:: Fidler, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.
Yazar:: Frater, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

How soon after HIV seroconversion is antiretroviral therapy initiated?
Yazar:: Babiker, A, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
Yazar:: Prendergast, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Early antiretroviral therapy is associated with better viral suppression and less HIV drug resistance after implementation of universal treatment in South Africa
Yazar:: Dorward, J, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy
Yazar:: Kroeze, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
Yazar:: Angus, B, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
Yazar:: Theodoulou, A, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Nicontine replacement therapy for smoking cessation
Yazar:: Silagy, G, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Response to combination antiretroviral therapy: variation by age.
Yazar:: Sabin, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
Yazar:: Kityo, C, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Nicotine replacement therapy for smoking cessation
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
Yazar:: Wolbers, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Nicotine replacement therapy for smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Viral therapy of cancer /
Yazar:: Harrington, Kevin J., 1958-, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation (Review)
Yazar:: Lindson, N, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
Yazar:: Touloumi, G, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Mathematical considerations of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads
Baskı/Yayın Bilgisi: (2003)

The effectiveness of nicotine replacement therapies in smoking cessation.
Yazar:: Silagy, C, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Management of antiretroviral therapy for HIV infection : analyzing when to change therapy
Baskı/Yayın Bilgisi: (2003)

Nicotine replacement therapy for smoking cessation.
Yazar:: Stead, L, ve diğerleri
Baskı/Yayın Bilgisi: (2012)